Understanding and addressing geography-related variability in referral pathways and NAC for TN and HER2+ breast cancer—for which local referral pathways, clinician knowledge and practice patterns, and resource availability may be underlying mechanisms—should be prioritized to improve the design of cancer systems. This evidence concerns the gene ERBB2 and breast cancer.